Table 1. Characteristics of the study population (n = 61).

^a Having hypertension, hyperlipidemia, or diabetes.

Abbreviations: AC, doxorubicin, cyclophosphamide; BMI, body mass index; FAC, fluorouracil, doxorubicin, cyclophosphamide; SD, standard deviation; T, taxotere; TAC, taxotere, adriamycin, and cyclophosphamide; TC, taxotere and cyclophosphamide.